Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Immunosuppression in HIV-infected Patients With Tuberculosis With Access to Antiretroviral Therapy in Primary Health Care Centres in Ethiopia - Clinical and Immunological Markers and Associations With Treatment Outcome

NCT01252537 is registered in ClinicalTrials.gov with Lund University as lead sponsor.

NCT NCT01252537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01252537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Immunosuppression in HIV-infected Patients With Tuberculosis With Access to Antiretroviral Therapy in Primary Health Care Centres in Ethiopia - Clinical and Immunological Markers and Associations With Treatment Outcome
Lead sponsor
Lund University
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
January 31, 2014
Enrollment
1,200 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection, immunosuppression, tuberculosis